SEC Form 4 · accession 0001127602-18-021893
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
George Massaro
Director
Period of report
Jun 25, 2018
Accepted (ET)
Jun 26, 2018 · 3:18 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 25, 2018 | S | 100 | $115.40 | D | 14,037 | D | |
| Common Stock | Jun 25, 2018 | S | 100 | $115.54 | D | 13,937 | D | |
| Common Stock | Jun 25, 2018 | S | 100 | $115.71 | D | 13,837 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale occurred pursuant to a 10b5-1 Trading Plan.